memantine

FDA Drug Profile — memantine hydrochloride, Memantine Hydrochloride, memantine

memantine is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand names including memantine hydrochloride, Memantine Hydrochloride, memantine. Available dosage forms: tablet, film coated, capsule, extended release, tablet.

Drug details

Generic Name
memantine
Brand Names
memantine hydrochloride, Memantine Hydrochloride, memantine
Application Number
ANDA090041
Sponsor
Amneal Pharmaceuticals LLC
NDC Codes
8
Dosage Forms
TABLET, FILM COATED, CAPSULE, EXTENDED RELEASE, TABLET
Routes
ORAL
Active Ingredients
MEMANTINE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Memantine hydrochloride tablets are indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Memantine hydrochloride tablets are an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.